The Health Care Select Sector SPDR® Fund Newsroom

"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".

① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.

cls.cn20:52 ET

Magnificent Seven Gain $700B After US-China Slash Tariffs, Gold Crashes: What's Driving Markets Monday?

Benzinga13:20 ET

Amedisys Edges Lower on Report DOJ Initially Rejects Remedy in UnitedHealth

Seeking Alpha13:17 ET

AbbVie Unusual Options Activity

Benzinga13:02 ET

The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.

① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.

cls.cn12:33 ET

Pharma Stocks Gain as Traders Have Doubts on Trump's Executive Order to Lower Drug Prices

MarketWatch12:11 ET

Cigna, CVS Down as Trump Targets 'Drug Middlemen' in Drug Prices EO

Seeking AlphaMay 12 11:15 ET

Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock

BenzingaMay 12 11:00 ET

Roche Plans $700M North Carolina Facility

Seeking AlphaMay 12 10:53 ET

Express News | President Trump Says U.S. Will Pay Same As Other Countries For Drugs; Republicans Can Do Better Than Obamacare; Drug Prices Will Affect Budget Deal; Will Cut Out Middlemen In Drug Sales; Will Help Drug Companies With Other Nations; Will Open Up U.S....

BenzingaMay 12 10:24 ET

Express News | President Trump Says EU Will Have To Pay More For Healthcare, We're Going To Have To Pay Less; Some Countries In Dire Need Might Be Helped Under Drug Policy

BenzingaMay 12 10:15 ET

Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House

Seeking AlphaMay 12 10:00 ET

Trump's Drug Price Cuts: Will They Work?

Moomoo News GlobalMay 12 09:35 ET

Sector Update: Health Care Stocks Advance Premarket Monday

MT NewswiresMay 12 09:20 ET

Leading And Lagging Sectors For May 12, 2025

BenzingaMay 12 09:10 ET

'Trump To Sign Order To Cut Some U.S. Drug Prices To Match Those Abroad' - CNBC

BenzingaMay 12 09:00 ET

Today's Pre-Market Movers and Top Ratings | TSLA, NVDA, LLY and More

Movers and ShakersMay 12 08:29 ET

House Republicans Push $880 Billion Medicaid Cuts To Renew Trump Tax Breaks—Democrat Warns: 'Millions Will Lose Their Health Care'

BenzingaMay 12 07:46 ET

Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'

BenzingaMay 12 07:40 ET

Eli Lilly and Co is directly competing with Novo-Nordisk A/S! The weight loss effect of Zepbound is far better than Wegovy.

① Eli Lilly and Co's weight loss drug Zepbound has a weight loss effect almost 50% greater than Novo-Nordisk A/S's Wegovy. After 72 weeks of treatment, patients in the Zepbound group lost an average of 50 pounds, while those in the Wegovy group lost 33 pounds; ② Although Zepbound shows better weight loss effects, both drugs are important for treating obesity, which affects approximately 40% of adults in the USA.

cls.cnMay 12 05:23 ET